Allosteric modulation of muscarinic receptors in alcohol and substance use disorders.
Addiction
Alcohol
Alcohol use disorder
Allosteric modulation
Cocaine
Extinction
Muscarinic receptors
Opioid
Reinstatement
Relapse
Self-administration
Substance use disorder
Journal
Advances in pharmacology (San Diego, Calif.)
ISSN: 1557-8925
Titre abrégé: Adv Pharmacol
Pays: United States
ID NLM: 9015397
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
18
5
2020
pubmed:
18
5
2020
medline:
30
9
2020
Statut:
ppublish
Résumé
Alcohol and substance use disorders are chronic relapsing disorders, characterized by a compulsion to take drugs and loss of control in limiting intake. The impact of alcohol and substance abuse on morbidity and mortality is very high worldwide, and treatment options are inadequate at a population level. There is a need for the discovery and development of novel pharmacotherapies to treat alcohol and substance use disorders. The recent development of subtype selective muscarinic acetylcholine receptor (mAChR) allosteric modulators, is rapidly increasing our understanding of this system and revealing great promise for disease treatment. In this chapter, we will present and integrate the current literature regarding the role of mAChRs in drug and alcohol abuse with emerging evidence using novel allosteric modulators targeting specific mAChR subtypes. We will focus on the potential of M
Identifiants
pubmed: 32416869
pii: S1054-3589(20)30003-X
doi: 10.1016/bs.apha.2020.01.003
pii:
doi:
Substances chimiques
Receptors, Muscarinic
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-275Informations de copyright
© 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest statement The authors have no conflicts of interest to declare.